Paul Finn, CSO, will be attending the 28th tRNA Conference, 12-16 June 2022 in Columbus, Ohio, USA.  On 13 June at 4:45pm EST Paul will be participating in a Panel Discussion on “Emerging Opportunities in tRNA Therapeutics”, which will showcase the emerging opportunities for translational science and entrepreneurism in tRNA-related therapeutics and biotechnology across multiple therapeutic areas and treatment modalities.  This is an exciting area with untapped therapeutic potential in which Oxford Drug Design is taking a leading position.